These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6832091)

  • 1. Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis.
    Eriksson L; Ahluwalia M; Spiewak J; Lee G; Sarma DS; Roomi MJ; Farber E
    Environ Health Perspect; 1983 Mar; 49():171-4. PubMed ID: 6832091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine.
    Hayes MA; Roberts E; Farber E
    Cancer Res; 1985 Aug; 45(8):3726-34. PubMed ID: 2861891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of metabolism of 2-acetylaminofluorene in carcinogen-induced hepatocyte nodules in comparison to normal liver.
    Spiewak Rinaudo JA; Farber E
    Carcinogenesis; 1986 Apr; 7(4):523-8. PubMed ID: 3698185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens.
    Farber E; Parker S; Gruenstein M
    Cancer Res; 1976 Nov; 36(11 Pt 1):3879-87. PubMed ID: 975037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate.
    Nagai MK; Farber E
    Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of resistance during the early stages of experimental liver carcinogenesis.
    Yusuf A; Rao PM; Rajalakshmi S; Sarma DS
    Carcinogenesis; 1999 Aug; 20(8):1641-4. PubMed ID: 10426821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
    Blanck A; Hällström IP; Eriksson LC
    Carcinogenesis; 1990 Jul; 11(7):1067-73. PubMed ID: 2372866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of glutathione to prevent liver cancer development in rats initiated with diethylnitrosamine in the resistant hepatocyte model.
    Ahluwalia MB; Rotstein J; Tatematsu M; Roomi MW; Farber E
    Carcinogenesis; 1983; 4(1):119-21. PubMed ID: 6821884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis.
    Enomoto K; Farber E
    Cancer Res; 1982 Jun; 42(6):2330-5. PubMed ID: 6122502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet.
    Aström A; DePierre JW; Eriksson L
    Carcinogenesis; 1983; 4(5):577-81. PubMed ID: 6850990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperplastic foci in chemical carcinogenesis].
    Rubenchik BL; Romanenko AM
    Tsitologiia; 1976 Sep; 18(9):1104-10. PubMed ID: 189470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some conclusions derived from a liver model for carcinogenesis.
    Cameron R; Farber E
    Natl Cancer Inst Monogr; 1981 Dec; (58):49-53. PubMed ID: 7341983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of cytochrome P-450 having arylhydrocarbon hydroxylase and increase of UDP-glucuronyltransferase glucuronizing phenolic xenobiotics in rat liver nodule.
    Yokota H; Ohgiya N; Yuasa A
    J Vet Med Sci; 1991 Aug; 53(4):683-90. PubMed ID: 1834210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene.
    Semple-Roberts E; Hayes MA; Armstrong D; Becker RA; Racz WJ; Farber E
    Int J Cancer; 1987 Nov; 40(5):643-5. PubMed ID: 3679591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.
    Tatematsu M; Nagamine Y; Farber E
    Cancer Res; 1983 Nov; 43(11):5049-58. PubMed ID: 6137276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver.
    Cameron R; Sweeney GD; Jones K; Lee G; Farber E
    Cancer Res; 1976 Nov; 36(11 Pt 1):3888-93. PubMed ID: 184917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.
    Cameron R; Kellen J; Kolin A; Malkin A; Farber E
    Cancer Res; 1978 Mar; 38(3):823-9. PubMed ID: 23897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of excretion of 2-acetylaminofluorene in normal and xenobiotic-treated rats and in rats with hepatocyte nodules.
    Rinaudo JA; Eriksson LC; Roomi MW; Farber E
    Lab Invest; 1989 Mar; 60(3):399-408. PubMed ID: 2927079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.